Literature DB >> 19006694

Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.

Jonathan A Hill1, Jason A Hall, Cheng-Ming Sun, Qi Cai, Norbert Ghyselinck, Pierre Chambon, Yasmine Belkaid, Diane Mathis, Christophe Benoist.   

Abstract

CD4(+)Foxp3(+) regulatory T (Treg) cells originate primarily from thymic differentiation, but conversion of mature T lymphocytes to Foxp3 positivity can be elicited by several means, including in vitro activation in the presence of TGF-beta. Retinoic acid (RA) increases TGF-beta-induced expression of Foxp3, through unknown molecular mechanisms. We showed here that, rather than enhancing TGF-beta signaling directly in naive CD4(+) T cells, RA negatively regulated an accompanying population of CD4(+) T cells with a CD44(hi) memory and effector phenotype. These memory cells actively inhibited the TGF-beta-induced conversion of naive CD4(+) T cells through the synthesis of a set of cytokines (IL-4, IL-21, IFN-gamma) whose expression was coordinately curtailed by RA. This indirect effect was evident in vivo and required the expression of the RA receptor alpha. Thus, cytokine-producing CD44(hi) cells actively restrain TGF-beta-mediated Foxp3 expression in naive T cells, and this balance can be shifted or fine-tuned by RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006694      PMCID: PMC3140207          DOI: 10.1016/j.immuni.2008.09.018

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

2.  Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

3.  Retinoic acid imprints gut-homing specificity on T cells.

Authors:  Makoto Iwata; Asami Hirakiyama; Yuko Eshima; Hiroyuki Kagechika; Chieko Kato; Si-Young Song
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

4.  High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.

Authors:  T Lufkin; D Lohnes; M Mark; A Dierich; P Gorry; M P Gaub; M LeMeur; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Retinoic acid suppression of human leukocyte interferon production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Immunopharmacology       Date:  1982-08

6.  Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.

Authors:  G Salbert; A Fanjul; F J Piedrafita; X P Lu; S J Kim; P Tran; M Pfahl
Journal:  Mol Endocrinol       Date:  1993-10

Review 7.  The retinoid signaling pathway: molecular and genetic analyses.

Authors:  P Chambon
Journal:  Semin Cell Biol       Date:  1994-04

8.  Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.

Authors:  R C Nicholson; S Mader; S Nagpal; M Leid; C Rochette-Egly; P Chambon
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

9.  RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

Authors:  J Y Chen; S Penco; J Ostrowski; P Balaguer; M Pons; J E Starrett; P Reczek; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.

Authors:  Ann E Herman; Gordon J Freeman; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  176 in total

Review 1.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

Review 2.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Karsten Kretschmer; Harald von Boehmer; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 4.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 5.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

Review 6.  Regulatory T-cell stability and plasticity in mucosal and systemic immune systems.

Authors:  M Murai; P Krause; H Cheroutre; M Kronenberg
Journal:  Mucosal Immunol       Date:  2010-05-26       Impact factor: 7.313

7.  Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.

Authors:  Gangzheng Hu; Zhongmin Liu; Changqing Zheng; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

8.  Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A-Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection.

Authors:  Yuejin Liang; Panpan Yi; Xiaofang Wang; Biao Zhang; Zuliang Jie; Lynn Soong; Jiaren Sun
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

Review 9.  The effects of all-trans retinoic acid on immune cells and its formulation design for vaccines.

Authors:  Xinyan Hao; Xiaofang Zhong; Xun Sun
Journal:  AAPS J       Date:  2021-02-24       Impact factor: 4.009

10.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.